[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100622347":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":22,"responsibleParty":137,"collaborators":10,"id":139,"slug":140,"hasResults":141,"nctId":142,"briefTitle":143,"officialTitle":144,"acronym":145,"eligibilityCriteria":146,"healthyVolunteers":141,"sex":147,"minAge":148,"maxAge":10,"enrollmentInfo":149,"targetDuration":10,"studyType":152,"phases":10,"briefSummary":153,"conditions":154,"keywords":156,"overallStatus":25,"whyStopped":10,"lastUpdateSubmitDate":158,"lastUpdatePostDateStruct":159,"startDateStruct":162,"completionDateStruct":164,"leadSponsor":166,"locationsCount":167},{"fullName":5,"class":6},"AbbVie","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Foslevodopa\u002FFoscarbidopa",null,"Participants will receive Foslevodopa\u002FFoscarbidopa as prescribed by their physician according to local label.",[13],{"name":14,"affiliation":5,"role":15},"ABBVIE INC.","STUDY_DIRECTOR",[17],{"name":18,"role":19,"phone":20,"phoneExt":10,"email":21},"Clementine Semanaz","CONTACT","844-663-3742","clementine.semanaz@abbvie.com",[23,37,46,56,65,75,85,90,100,110,119,128],{"facility":24,"status":25,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":10},"Imelda Ziekenhuis \u002FID# 279436","RECRUITING","Bonheiden","Antwerpen","2820","Belgium","BE",{"type":32,"coordinates":33},"Point",[34,35],4.54714,51.02261,{"lat":35,"lon":34},{"facility":38,"status":25,"city":39,"state":27,"zip":40,"country":29,"countryCode":30,"cosmosGeoPoint":41,"geoPoint":45,"contacts":10},"Universitair Ziekenhuis Antwerpen \u002FID# 279434","Edegem","2650",{"type":32,"coordinates":42},[43,44],4.44504,51.15662,{"lat":44,"lon":43},{"facility":47,"status":25,"city":48,"state":49,"zip":50,"country":29,"countryCode":30,"cosmosGeoPoint":51,"geoPoint":55,"contacts":10},"Chu Tivoli \u002FID# 279455","La Louvière","Hainaut","7100",{"type":32,"coordinates":52},[53,54],4.18785,50.48657,{"lat":54,"lon":53},{"facility":57,"status":25,"city":58,"state":49,"zip":59,"country":29,"countryCode":30,"cosmosGeoPoint":60,"geoPoint":64,"contacts":10},"Centre Hospitalier De Wallonie Picarde - Site Notre Dame \u002FID# 279452","Tournai","7500",{"type":32,"coordinates":61},[62,63],3.38932,50.60715,{"lat":63,"lon":62},{"facility":66,"status":25,"city":67,"state":68,"zip":69,"country":29,"countryCode":30,"cosmosGeoPoint":70,"geoPoint":74,"contacts":10},"Jessa Ziekenhuis - Campus Virga Jesse \u002FID# 279454","Hasselt","Limburg","3500",{"type":32,"coordinates":71},[72,73],5.33781,50.93106,{"lat":73,"lon":72},{"facility":76,"status":25,"city":77,"state":78,"zip":79,"country":29,"countryCode":30,"cosmosGeoPoint":80,"geoPoint":84,"contacts":10},"AZ Sint-Lucas \u002FID# 279453","Ghent","Oost-Vlaanderen","9000",{"type":32,"coordinates":81},[82,83],3.71667,51.05,{"lat":83,"lon":82},{"facility":86,"status":25,"city":77,"state":78,"zip":79,"country":29,"countryCode":30,"cosmosGeoPoint":87,"geoPoint":89,"contacts":10},"UZ Gent \u002FID# 279433",{"type":32,"coordinates":88},[82,83],{"lat":83,"lon":82},{"facility":91,"status":25,"city":92,"state":93,"zip":94,"country":29,"countryCode":30,"cosmosGeoPoint":95,"geoPoint":99,"contacts":10},"Universitair Ziekenhuis Leuven \u002FID# 279439","Leuven","Vlaams-Brabant","3000",{"type":32,"coordinates":96},[97,98],4.70093,50.87959,{"lat":98,"lon":97},{"facility":101,"status":25,"city":102,"state":103,"zip":104,"country":29,"countryCode":30,"cosmosGeoPoint":105,"geoPoint":109,"contacts":10},"Algemeen Ziekenhuis Sint-Jan Brugge \u002FID# 279422","Bruges","West-Vlaanderen","8000",{"type":32,"coordinates":106},[107,108],3.22424,51.20892,{"lat":108,"lon":107},{"facility":111,"status":25,"city":112,"state":103,"zip":113,"country":29,"countryCode":30,"cosmosGeoPoint":114,"geoPoint":118,"contacts":10},"Az Groeninge Campus Kennedylaan \u002FID# 279423","Kortrijk","8500",{"type":32,"coordinates":115},[116,117],3.26487,50.82803,{"lat":117,"lon":116},{"facility":120,"status":25,"city":121,"state":103,"zip":122,"country":29,"countryCode":30,"cosmosGeoPoint":123,"geoPoint":127,"contacts":10},"AZ Oostende \u002FID# 279461","Ostend","8400",{"type":32,"coordinates":124},[125,126],2.927,51.21551,{"lat":126,"lon":125},{"facility":129,"status":25,"city":130,"state":103,"zip":131,"country":29,"countryCode":30,"cosmosGeoPoint":132,"geoPoint":136,"contacts":10},"AZ-Delta. \u002FID# 279437","Roeselare","8800",{"type":32,"coordinates":133},[134,135],3.12269,50.94653,{"lat":135,"lon":134},{"type":138,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100622347","a-study-to-assess-change-in-disease-symptoms-in-adult-participants-with-advanced-parkinson-disease-using-subcutaneous-foslevodopafoscarbidopa-in-belgium-100622347",false,"NCT07382440","A Study to Assess Change in Disease Symptoms in Adult Participants With Advanced Parkinson Disease Using Subcutaneous Foslevodopa\u002FFoscarbidopa in Belgium","Observational Prospective Study to Evaluate Effectiveness of Subcutaneous Treatment With Foslevodopa\u002FFoscarbidopa in Real Life Setting for Advanced Parkinson's Disease Patients in Belgium.","ProParkB","Inclusion Criteria:\n\n* Participant diagnosed with Advanced Parkinson's Disease (PD), aged 18 years or older able to provide voluntary informed consent.\n* Participant evaluated for commercially available continuous subcutaneous Foslevodopa\u002FFoscarbidopa (LDp\u002FCDp) in the hospital at the clinician's discretion as part of his\u002Fher routine clinical care and the intention to administer subcutaneous LDp\u002FCDp made prior to and independent of recruitment into the study.\n\nExclusion Criteria:\n\n* Participant participating in an interventional research study (not including noninterventional studies) during the administration of LDp\u002FCDp.\n* Participant evaluated for commercially available continuous subcutaneous LD\u002FCDp outside of the hospital.","ALL","18 Years",{"count":150,"type":151},120,"ESTIMATED","OBSERVATIONAL","Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. This study will assess how effective Foslevodopa\u002FFoscarbidopa is in treating adult participants with advanced Parkinson Disease under routine clinical practice in Belgium.\n\nFoslevodopa\u002FFoscarbidopa is an approved drug for the treatment of Parkinson's Disease. Approximately 120 adult participants who are prescribed Foslevodopa\u002FFoscarbidopa by their doctors will be enrolled at 15 sites across Belgium.\n\nParticipants will receive Foslevodopa\u002FFoscarbidopa subcutaneous infusion as prescribed by their physician. Participants will be followed for up to 18 months.\n\nThere is expected to be no additional burden for participants in this trial. Participants will attend regular visits during the study at a hospital or clinic according to their routine clinical practice.",[155],"Parkinson's Disease",[157,9],"Parkinson's Disease: Advanced Parkinson's Disease","2026-06-23",{"date":160,"type":161},"2026-06-25","ACTUAL",{"date":163,"type":161},"2026-03-09",{"date":165,"type":151},"2028-09",{"name":5,"class":6},12]